#neoadjuvant — Tuesday, September 01, 2026 (1 items)
| 0 | ℹ |
Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial.
(nature.com)
|
Nature Medicine 2026-09-01 | #clinical trial #immunotherapy #breast cancer #neoadjuvant #checkpoint inhibitor |